ACM
TECH icon

Absolute Capital Management’s Bio-Techne TECH Stock Holding History

Absolute Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-132
Closed -$9.39K – 449
2022
Q3 		$9.39K Buy
+132
New +$11.4K 0.01% 172
2022
Q1 		– Sell
-160
Closed -$20.7K – 435
2021
Q4 		$20.7K Buy
+160
New +$19.6K 0.02% 149

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Absolute Capital Management's TECH Position: Q4 2022 in Review

Absolute Capital Management sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 132 shares — an estimated $9.39K sold.

Absolute Capital Management first reported a position in TECH in Q4 2021 and held it in 2 quarters. The position peaked at $20.7K in Q4 2021. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • Absolute Capital Management reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • Absolute Capital Management sold 132 Bio-Techne shares in Q4 2022, an estimated $9.39K.
  • Absolute Capital Management first reported a position in Bio-Techne in Q4 2021 and held it in 2 quarters.
  • Absolute Capital Management's Bio-Techne position peaked at $20.7K in Q4 2021.
  • 545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Absolute Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.